MIFH
IONS icon

Migdal Insurance & Financial Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,305
Closed -$598K – 629
2021
Q1 		$598K Buy
13,305
+8,257
+164% +$461K 0.01% 302
2020
Q4 		$285K Buy
+5,048
New +$252K ﹤0.01% 273

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IONS Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 13,305 shares — an estimated $598K sold.

Migdal Insurance & Financial Holdings first reported a position in IONS in Q4 2020 and held it in 2 quarters. The position peaked at $598K in Q1 2021. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 13,305 Ionis Pharmaceuticals shares in Q2 2021, an estimated $598K.
  • Migdal Insurance & Financial Holdings first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Ionis Pharmaceuticals position peaked at $598K in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.